Castle Biosciences Inc (CSTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 114,821 | 122,948 | 134,180 | 273,166 | 309,017 |
| Marketable Securities | 117,234 | 135,677 | 131,802 | N/A | N/A |
| Receivables | 27,728 | 23,476 | 22,835 | 22,606 | 19,910 |
| Inventories | 4,520 | 3,980 | 3,802 | 3,365 | 2,350 |
| TOTAL | $271,100 | $292,288 | $299,414 | $304,912 | $336,441 |
| Non-Current Assets | |||||
| PPE Net | 18,254 | 14,315 | 13,054 | 11,203 | 9,385 |
| Intangibles | 0 | 0 | 0 | 0 | 87,275 |
| Other Non-Current Assets | 137,537 | 140,726 | 145,343 | 142,265 | 11,324 |
| TOTAL | $155,791 | $155,041 | $158,397 | $153,468 | $107,984 |
| Total Assets | $426,891 | $447,329 | $457,811 | $458,380 | $444,425 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9,961 | 4,731 | 5,768 | 3,281 | 3,314 |
| Accrued Expenses | 12,796 | 24,358 | 19,532 | 14,850 | 8,566 |
| Other current liabilities | N/A | N/A | N/A | N/A | 20,849 |
| TOTAL | $30,143 | $36,128 | $31,942 | $27,519 | $39,521 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 11,158 | 11,623 | 13,822 | 8,587 | 6,711 |
| TOTAL | $11,599 | $12,051 | $14,436 | $9,201 | $7,568 |
| Total Liabilities | $41,742 | $48,179 | $46,378 | $36,720 | $47,089 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 26,691 | 26,576 | 26,352 | 26,297 | 26,261 |
| Common Shares | 27 | 27 | 26 | 26 | 25 |
| Retained earnings | -190,109 | -160,905 | -140,287 | -120,038 | -118,390 |
| Other shareholders' equity | -136 | -381 | -189 | 0 | 0 |
| TOTAL | $385,149 | $399,150 | $411,433 | $421,660 | $397,336 |
| Total Liabilities And Equity | $426,891 | $447,329 | $457,811 | $458,380 | $444,425 |